T. Aalto

发表

Insiders´ views as a predictor of stock performance : can insider trading be used to predict stock performance on the United States stock market?

T. Aalto, 2013 .

Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment

R. Devereux, J. Bella, V. Palmieri, 2002 .

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.

G. Aurigemma, R. Devereux, J. Bella, 2001, The American journal of cardiology.

Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.

Jackson T. Wright, R. Devereux, K. Borch-Johnsen, 2002, American heart journal.

Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).

R. Devereux, J. Bella, V. Palmieri, 2002, The American journal of cardiology.

Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).

G. Aurigemma, J. Bella, V. Palmieri, 2010, The American journal of cardiology.

Magnetocardiographic Assessment of Left Ventricular Hypertrophy: Correlation with Echocardiography

M. Nieminen, T. Katila, J. Nenonen, 2000 .

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

R. Devereux, J. Bella, M. Roman, 2000, Hypertension.

Change in Diastolic Left Ventricular Filling After One Year of Antihypertensive Treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

R. Devereux, J. Bella, V. Palmieri, 2002, Circulation.